免疫健全小鼠模型再现病毒诱导肝纤维化与肝细胞癌
研究采用与丙型肝炎病毒(HCV)近缘的挪威大鼠肝炎病毒(NrHV)感染免疫健全实验室小鼠,评估慢性肝炎、进行性肝纤维化及肝细胞癌(HCC)的发生。结果显示慢性NrHV感染可诱导持续性肝炎、进行性肝纤维化和HCC,肿瘤及肝转录组特征与人类HCV相关疾病高度相似,建立了首个免疫健全、可模拟从慢性病毒性肝炎到自发性HCC多阶段进程的感染模型。
要点
- 慢性NrHV感染免疫健全小鼠可诱导持续性肝炎、进行性肝纤维化及HCC。
- NrHV诱导的肿瘤与HCV相关肿瘤高度相似,转录组通路改变一致。
- 该模型为病毒相关HCC机制及抗纤维化/抗癌策略研究提供平台。
核心结论
- 慢性NrHV感染免疫健全小鼠可诱导持续性肝炎、进行性肝纤维化和HCC,建立了一个生理相关且免疫健全的病毒诱导肝纤维化与肝癌模型。
研究设计与样本
- 研究采用与HCV近缘的挪威大鼠肝炎病毒(NrHV)感染免疫健全实验室小鼠,评估慢性肝炎、进行性肝纤维化及HCC的发生。
- 对肝脏肿瘤进行组织学和分子学表征,并分析肝脏转录组以比较NrHV诱导的变化与人类HCV相关疾病。
主要发现
- 慢性NrHV感染在免疫健全小鼠中诱导持续性肝炎、进行性肝纤维化和HCC。
- NrHV诱导的肿瘤与HCV相关肿瘤高度相似。
- 转录组分析显示慢性NrHV感染小鼠与人类HCV感染在纤维化、炎症和致癌相关通路改变上存在众多相似性。
临床怎么用
- 该模型可用于研究病毒-宿主相互作用驱动的纤维化和致癌机制。
- 该模型可在自然感染背景下研究自发性肿瘤发展,用于严格测试抗纤维化和抗癌策略。
- 病毒清除后致癌潜能持续存在,提示需关注病毒治愈后疾病重编程和癌症风险升高的问题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) is the third deadliest cancer worldwide. Over 75% of HCC cases are associated with chronic viral infections. Mechanistic studies and preclinical therapeutic development for virus-associated HCC have been limited by a paucity of small animal models of chronic hepatotropic virus infection that faithfully recapitulate human disease. METHODS: We investigated chronic viral infection with Norway rat hepacivirus (NrHV) - a virus closely related to HCV - in immunocompetent laboratory mice. We assessed the development of chronic hepatitis, progressive liver fibrosis, and HCC. Liver tumors were histologically and molecularly characterized, and liver transcriptomes were analyzed to compare NrHV-induced changes with those observed in human HCV-associated disease. RESULTS: Chronic NrHV infection induced persistent hepatitis, progressive liver fibrosis, and HCC in immunocompetent mice. NrHV-elicited tumors closely resembled HCV-associated tumors. Transcriptome analyses revealed numerous similarities between chronic NrHV infection in mice and HCV infection in humans, including changes in pathways associated with fibrosis, inflammation, and oncogenesis. CONCLUSIONS: These findings establish an experimentally tractable, physiologically relevant, and immunocompetent mouse model of virus-elicited progressive liver fibrosis and oncogenesis. IMPACT AND IMPLICATIONS: The Norway rat hepacivirus-induced hepatocellular carcinoma model represents the first immunocompetent infectious system that faithfully recapitulates the multistage progression from chronic viral hepatitis to spontaneous hepatocellular carcinoma, bridging a long-standing translational gap between mechanistic mouse studies and human liver cancer. By mirroring the immunopathological, molecular, and sex-associated features of chronic HCV infection, this model provides an unparalleled platform to investigate virus-host interactions underlying fibrosis and oncogenesis. High hepatocellular carcinoma incidence and the genetically tractable C57BL/6 background further enhance experimental utility, enabling precise mechanistic dissection and genetic manipulation in a physiologically relevant setting. The capacity to study spontaneous tumor development in the context of natural infection allows for rigorous testing of antifibrotic and anti-cancer strategies, while the persistence of oncogenic potential after viral clearance raises important questions about irreversible disease reprogramming and elevated cancer risk following viral cure - issues of direct relevance to patients cured of HCV.
引用
- Batista MN, Bordignon J, P Mosimann AL, et al. An immunocompetent murine model of virus-elicited liver fibrosis and hepatocellular carcinoma. J Hepatol. 2026. PMID: 41825745. doi:10.1016/j.jhep.2026.02.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。